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This story is important because it involves, to our 
knowledge, the first-ever broad-based high-sensitivity 
testing of ship-in stalls at a North American racetrack. The 
story begins in August 2015, when Charles Town Races 
changed its drug-testing contract to the highly capable 
Denver-based Industrial Laboratories and also adopted the 
Racing Medication and Testing Consortium (RMTC) controlled 
therapeutic medication schedule. 
One unanticipated outcome of these changes was the 
appearance of a sporadic sequence of low-concentration 
naproxen positives, mostly among trainers shipping in from 
Mid-Atlantic states to race at Charles Town. As of January 1, 
2017, these identifications were all in plasma and ran from 
a miniscule 6.3 ng/ml to 161 ng/ml. Although these plasma 
concentrations of naproxen are readily detectable by modern, 
high-sensitivity testing methods, these concentrations are 
not pharmacologically significant, especially given that the 
neighboring Mid-Atlantic states were regulating naproxen at 
a 1,000 ng/ml plasma threshold.
Naproxen is the poster child for stall contamination. 
The naproxen dose is large—5 grams/horse twice a day, 
given orally. The stall becomes contaminated beginning with 
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the naproxen that inadvertently drips there with the first oral dose and soon 
thereafter with the naproxen-laden urine that the horse spills into the stall. 
The naproxen molecule is chemically stable, so it persists and will accumulate 
in the stall. One way to tell if a stall is contaminated is to put a “clean” horse 
into the stall and test the horse in a couple of days; if the stall is significantly 
contaminated, the horse will test positive for naproxen.
Where were the naproxen positives in the Charles Town ship-ins coming 
from? One possibility suggested by horsemen was that the ship-in stalls 
themselves were naproxen-contaminated, providing a ready source of the 
naproxen positives. Responding to this suggestion, West Virginia Racing 
Commission personnel swabbed the ship-in stalls and sent the samples 
to Industrial Laboratories for analysis, leading to some, shall we say, very 
interesting findings. 
Presented below are data from the reports from Industrial Laboratories to 
the West Virginia Racing Commission obtained under a public records request 
by the Charles Town HBPA. We do not know precisely how the stalls were 
swabbed/sampled; nevertheless, the results are very interesting indeed. And, 
by way of background, the total number of ship-in stalls tested was 21, and 
of that number, only four were negative for detected medications/substances, 
starting with human recreational substances, as presented in Figure 1. One 
additional stall had straw tested, and the straw was negative.
As shown in Figure 1, cocaine and its 
metabolites benzoylecgonine (BZE) and 
ecgonine methyl ester were, not surprisingly, 
the most frequently identified substances, 
identified in 10 of the ship-in stalls tested. 
This finding is fully consistent with the 
widespread human recreational use of cocaine 
and its well-established presence as a trace-
level environmental substance in human 
environments. Traces of cocaine can be found 
on 92 percent of circulating U.S. dollars. As a 
result of the ubiquitous presence of cocaine in 
the human environment, the Federal Aviation 
Administration, Nuclear Regulatory Commission 
and the U.S. Department of Transportation have 
adopted a screening level of 150 ng/ml of its 
BZE metabolite in human urine as not unusual 
and indicative of nothing more than inadvertent 
exposure of the human to trace-level amounts 
of environmental cocaine. Similarly, some 
horse racing jurisdictions have adopted a BZE 
screening limit, ranging from 50 ng/ml to 150 
ng/ml in a post-race urine sample.
Methamphetamine is also a widely used 
human recreational substance, and there were 
two amphetamine and one methamphetamine 
identifications, fully consistent with the 
increasingly common detection of trace levels 
of methamphetamine in racing. One other 
identification most likely related to human 
recreational substance use was an identification 
of methylenedioxypyrovalerone (MDPV) or 
“bath salts” and an unexpected identification 
of n-ethylnicotinamide, a metabolite of the 
stimulant nikethamide. All in all, it is clear 
confirmation of the widespread presence in the 
racing environment, in this case in ship-in stalls, 
of traces of human recreational substances. 
ALL IN ALL, IT IS CLEAR CONFIRMATION OF 
THE WIDESPREAD PRESENCE IN THE RACING 
ENVIRONMENT, IN THIS CASE IN SHIP-IN  
STALLS, OF TRACES OF HUMAN  
RECREATIONAL SUBSTANCES. 
FIGURE 1:  HUMAN RECREATIONAL SUBSTANCES FOUND  
IN THE SHIP-IN STALLS AT CHARLES TOWN RACES
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A total of 14 human prescription or over-the-counter 
medication identifications were found in these 21 stalls, 
shown in Figure 2. There were three identifications of 
metoprolol, a human blood pressure medication; two each 
of tramadol, a human opioid-type pain medication; and 
methadone, an opioid used to treat pain and also as a 
maintenance therapy for humans with opioid dependence. 
One stall tested positive for oxycodone, an opioid widely 
misused by humans in the current opioid epidemic in the 
United States, for a total of five opiate identifications. 
There were two identifications of metformin, a widely 
used human type 2 diabetes medication, and two 
identifications of meprobamate, a long-used human anti-
anxiety medication, as well as a metabolite of carisoprodol 
(Soma), a commonly prescribed human muscle relaxant 
that is also occasionally used in horses. 
Not entirely unexpectedly, there was one identification 
listed as levorphanol/dextrorphan, presumably a passed-
through metabolite of dextromethorphan, the active 
substance in a number of over-the-counter medications 
such as NyQuil, as evidenced in a number of recent 
dextrorphan identifications in Kentucky associated with 
the use of NyQuil by the groom of at least one of the 
involved horses. Finally, there was an identification of 
ritalinic acid, presumably associated with urination 
in the ship-in stall of an individual medicated with 
methylphenidate/Ritalin. These ship-in stall findings of 
tramadol, oxycodone and dextrorphan come as no surprise 
to the racing community, with these substances being 
identified as human prescription and over-the-counter 
medications long suspected of transferring from humans 
to racehorses and giving rise to trace-level urinary 
identifications of these substances. 
Finally, the equine substances (Figure 3) present in 
the ship-in stalls totaled 21 individual identifications. The 
status of naproxen was reported as “high-concentration” 
in four stalls but was apparently detected at a low level in 
almost all of the tested stalls, consistent with its poster-
child status as an environmental substance. Three stalls 
each tested positive for acepromazine and glycopyrrolate, 
which is somewhat surprising for these relatively low-dose 
medications. Two stalls each tested positive for ketoprofen 
and flunixin. The flunixin findings were consistent with 
its long-established role as a stall contaminant, even 
when administered as an IV medication. There was 
also one stall identification each of firocoxib, a high-
dose non-steroidal anti-inflammatory; guaifenesin; 
isoxsuprine, another poster child for stall contamination; 
a somewhat unexpected lidocaine; a fully to be expected 
methocarbamol; and two not unexpected equine/human 
anti-ulcer medications, omeprazole and ranitidine.
FIGURE 2:  HUMAN THERAPEUTIC SUBSTANCES FOUND IN THE  
SHIP-IN STALLS AT CHARLES TOWN RACES
FIGURE 3:  EQUINE THERAPEUTIC SUBSTANCES FOUND IN THE  
SHIP-IN STALLS AT CHARLES TOWN RACES
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THE CASE FOR ENVIRONMENTAL EXPOSURE GROWS
This space in The Horsemen’s Journal has been repeatedly filled with 
examples of positive tests resulting from inadvertent environmental exposure 
that have been implicated from sources as widely varied as contamination 
from a groom’s hands of common cold remedies to the horse’s own urine. We 
have discussed possible transfer from human urine, traces of medication on 
hay nets, commingling of human prescriptions with tongue ties in pockets 
or even transferred from the hands of an assistant starter onto the horse’s 
mucous membranes. While some of these sources could be readily limited 
by strict control by the trainer, others are completely outside the control of 
horsemen. Nonetheless, the absolute insurer rule counts these meaningless 
positive tests as equal to intentional administration of performance-enhancing 
drugs. Some regulators, such as the Kentucky Horse Racing Commission, in the 
case of dextrorphan, have come to the logical conclusion that some such trace-
positive findings are irrelevant, whereas others continue to adhere to their 
outdated zero-tolerance regulations.
THE EVIDENCE
Drugs in the environment are an emerging problem, not just for horse 
racing, and it has entered the radar screen of our national regulatory bodies. 
The Environmental Protection Agency commissioned a study evaluating the 
effluents of 50 large wastewater treatment plants and found measurable levels 
of 56 different pharmaceuticals, with a diuretic, hydrochlorothiazide, being 
found in every sample analyzed. Among the drugs found were hypertensive 
medications, metoprolol, atenolol, enalapril and narcotics, including 
hydrocodone and oxycodone. Some of these drugs result from the flushing of 
prescription drugs down the toilet, but most are actually from the urine of 
humans taking the drugs. The levels of these environmental contaminants 
in wastewater are mostly very low, unlikely to cause positive tests in 
racing horses, but it underscores the significance of contamination in the 
environment. Environmental contamination happens, with many of these drugs 
stable enough in the environment to remain in the water even after wastewater 
treatment.
More common sources of inadvertent environmental exposure for horses 
are the horses themselves, the grooms in constant contact with the horses 
under their care and others like racing officials. There has been credible 
evidence of contamination of horses by casual contact with grooms, paddock 
judges and assistant starters, and even contamination of blood or urine 
samples during or after collection in the test barn. All of these positive tests 
have been at very low, trace levels of identification, usually in urine, and at 
levels well below those that may affect the physiology of the animal.
The problem of inadvertent environmental exposure was first outlined in a 
group of scientific papers published in 2000 at the International Conference for 
Racing Analysts and Veterinarians. In those proceedings, naproxen, ibuprofen, 
isoxsuprine and flunixin were all shown to have positive tests consistent with 
violations after exposure to very low concentrations of these drugs. In 2006 
chlorpheniramine, dipyrone and meclofenamic acid were added to the list of 
drugs for which such positives could be demonstrated. Recommended limits of 
detection were suggested for therapeutic medications to avoid these irrelevant 
positives from inadvertent environmental exposure.
The phenomenon of inadvertent environmental exposure to horses by their 
own urine was clearly demonstrated in 2011 in a study by Dr. Marie-Agnès 
Popot and others in France. They administered flunixin orally and intravenously 
and bedded the horses on straw. The horses were grouped as follows: 
1) those in deep stall bedding that was completely stripped and swept out 
daily, 
2) those in thin stall bedding that was completely stripped and swept  
out daily, and
3) those in deep stall bedding cleaned in the usual fashion with most of 
the straw saved and the dirty removed. 
At 24 hours after the drug was given, a horse was moved to a clean 
stall in which no horse had been given flunixin. The findings were simple: All 
groups, except the horse that was moved to a clean stall, experienced positive 
tests associated with recycling of flunixin from the stall. The highest risk of a 
positive test from this stall contamination was in the group with thin bedding 
completely stripped daily. 
DRUGS IN THE ENVIRONMENT
In 2008 Dr. Steven Barker performed a survey of the test barn and 
receiving barn stalls at a racetrack in Louisiana. He sampled the dirt floors, 
consciously avoiding regions of high suspicion, such as obvious areas of urine 
and fecal contamination, collecting about 1 ½ ounces of dirt to screen for 
drugs. He looked for common equine therapeutic medications, caffeine and 
cotinine, a metabolite of nicotine. Phenylbutazone, flunixin, naproxen, caffeine 
and furosemide were all readily identified in those stall samples, and all of the 
samples collected contained cotinine. While none of those drugs were present 
in sufficient concentrations to actually trigger a positive test, this study shows 
that, even in what are expected to be the cleanest areas on the backside—the 
test and receiving barns, where horses are generally not actually treated with 
drugs routinely—the environment is contaminated with medications.
In the last edition of The Horsemen’s Journal, we outlined an investigation of 
a cluster of naproxen positives at Charles Town. As stated earlier, the stalls in the 
receiving barn were swabbed and tested for drugs in the environment as part of 
the investigation by the West Virginia Racing Commission into this incident.
Several points can be surmised from the results. First, many of 
the substances found in the stalls at Charles Town are found in trace 
concentrations in post-race samples, often with the trainer and owner left 
wondering where they came from. Second, these were the substances found in 
the ship-in barn, and some substances, such as equine therapeutics, would be 
expected to be much higher in the horses’ home stalls. Third, it is critical that 
these studies be repeated at racetracks across the country; the absolute insurer 
rule cannot hold a trainer responsible for substances inadvertently picked up 
by a horse in a receiving barn, test barn or other area not under their direct 
control. Finally, these issues can readily be addressed using recommended 
screening limits, like the limits of detection originally recommended by Duluard 
and others in 2006, for substances of inadvertent environmental exposure. 
RCI MODEL RULES
ARCI-025-020§H2 recognizes that “substances of human use and 
addiction and which could be found in the horse due to its close association 
with humans” should be identified, but as yet, there are no screening limits 
established for such substances in the model rules.
The National HBPA and North American Association of Racetrack 
Veterinarians have joined together to propose screening limits for three of the 
substances of concern, two of which are prominently featured in the Charles 
Town investigation: methamphetamine and cocaine and its metabolites. We 
urge jurisdictions to consider our proposal in light of the evidence outlined 
in this article and join us in moving horse racing past the penalizing of our 
horsemen and owners because of highly sensitive testing equipment.  
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